Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genetic Signatures Ltd. (AU:GSS)
ASX:GSS
RESEARCH TOOLSreports
Genetic Signatures Ltd. (GSS) Share Price & Analysis
1 Followers
GSS Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.38 - AU$0.76
Previous CloseAU$0.69
Volume1.36K
Average Volume (3M)130.61K
Market Cap
AU$129.63M
Enterprise ValueAU$91.81M
Total Cash (Recent Filing)AU$36.90M
Total Debt (Recent Filing)AU$34.00K
Price to Earnings (P/E)-5.5
Beta0.50
Next Earnings
Aug 28, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares OutstandingN/A
10 Day Avg. Volume179,195
30 Day Avg. Volume130,608
Standard Deviation0.17
R-Squared0.03
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
3.34% Insiders
<0.01% Mutual Funds
0.00% Other Institutional Investors
96.65% Public Companies and
Individual Investors
GSS FAQ
What was Genetic Signatures Ltd.’s price range in the past 12 months?
Genetic Signatures Ltd. lowest share price was AU$0.38 and its highest was AU$0.76 in the past 12 months.
What is Genetic Signatures Ltd.’s market cap?
Currently, no data Available
When is Genetic Signatures Ltd.’s upcoming earnings report date?
Genetic Signatures Ltd.’s upcoming earnings report date is Aug 28, 2024 which is in 127 days.
How were Genetic Signatures Ltd.’s earnings last quarter?
Genetic Signatures Ltd. released its earnings results on Feb 21, 2024. The company reported -AU$0.073 earnings per share for the quarter, missing the consensus estimate of -AU$0.034 by -AU$0.039.
Is Genetic Signatures Ltd. overvalued?
According to Wall Street analysts Genetic Signatures Ltd.’s price is currently Overvalued.
Does Genetic Signatures Ltd. pay dividends?
Genetic Signatures Ltd. does not currently pay dividends.
What is Genetic Signatures Ltd.’s EPS estimate?
Genetic Signatures Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genetic Signatures Ltd. have?
Genetic Signatures Ltd. has 186,482,640 shares outstanding.
What happened to Genetic Signatures Ltd.’s price movement after its last earnings report?
Genetic Signatures Ltd. reported an EPS of -AU$0.073 in its last earnings report, missing expectations of -AU$0.034. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Genetic Signatures Ltd.?
Currently, no hedge funds are holding shares in AU:GSS
---
Genetic Signatures Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:GSS Sentiment 66%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth AU$263.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-16.86%
12-Months-Change
Fundamentals
Return on Equity
-40.28%
Trailing 12-Months
Asset Growth
-16.99%
Trailing 12-Months
Company Description
Genetic Signatures Ltd.
Genetic Signatures Ltd is a molecular diagnostics company. The company is engaged in the development and commercialization of its proprietary platform technology, 3Base. The firm operates under one business segment namely the research and commercialisation of identifying individual genetic signatures to identify diseases and disabilities. It offers various detection kits under the brand EasyScreen in order to detect different infectious diseases including gastroenteritis, respiratory diseases, meningitis pathogens, among others.
---
GSS Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Integral Diagnostics Ltd.
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
OncoSil Medical Ltd
―
Best Analysts Covering GSS
1 Year
1 Year Success Rate
2/2 ratings generated profit
1 Year Average Return
+19.85%
reiterated a buy rating 7 months ago
Copying Dennis Hulme's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +19.85% per trade.
---